Publikation
The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly.
Wissenschaftlicher Artikel/Review - 09.12.2022
Rothe Thomas, von Garnier Christophe, Bridevaux Pierre-Olivier, Charbonnier Florian, Clarenbach Christian, Gianella Pietro, Jochmann Anja, Kern Lukas, Nikolay Pavlov, Steurer-Stey Claudia, Leuppi Joerg D
Bereiche
PubMed
DOI
Kontakt
Zitation
Art
Zeitschrift
Veröffentlichungsdatum
eISSN (Online)
Seiten
Kurzbeschreibung/Zielsetzung
Over 20 years ago, the concept of asthma control was created and appropriate measurement tools were developed and validated. Loss of asthma control can lead to an exacerbation. Years ago, the term "clinically significant asthma exacerbation" was introduced to define when a loss of control is severe enough to declare it an asthma exacerbation. This term is also used by health insurances to determine when an exacerbation is eligible for reimbursement of biologics in clinical practice, however, it sometimes becomes apparent that a clear separation between loss of "asthma control" and an exacerbation is not always possible. In this review, we attempt to justify why exacerbations in early allergic asthma and adult eosinophilic asthma can differ significantly and why this is important in clinical practice as well as when dealing with health insurers.